SomnoMed® is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Frisco, Texas was opened in 2006 thus introducing their leading device technology to patients in America. To date there have been over 200,000 patients around the world who have been treated with SomnoDent!
SomnoMed is the global leader in COAT™ (Continuous Open Airway Therapy) and provides clinically proven diagnostic and treatment options for sleep-related breathing disorders such as obstructive sleep apnea (OSA) and sleep bruxism.
How we do business is a critical success factor for SomnoMed and our company’s mission, vision and values are linked together to drive what we do every day.
To delight our customers and patients with the highest quality products and services for the treatment of Obstructive Sleep Apnea (OSA)
To be recognized as the most innovative and fastest growing medical device company in the Continuous Open Airway Therapy (COAT) market